Clopidogrel resistance
Last updated 24 Nov 2023
Meets Patient’s editorial guidelines
- DownloadDownload
- Share
- Language
- Discussion
- Ask Patient
- Audio Version
- Add to preferred sources on Google
Clopidogrel resistance is a condition in which the drug clopidogrel is less effective than normal in people who are treated with it. Clopidogrel (also known as Plavix) is an antiplatelet drug, which means that it prevents blood cells called platelets from sticking together (aggregating) and forming blood clots. This drug is typically given to prevent blood clot formation in individuals with a history of stroke; heart attack; a blood clot in the deep veins of the arms or legs (deep vein thrombosis); or plaque buildup (atherosclerosis) in the blood vessels leading from the heart, which are opened by placement of a small thin tube (stent).
Video picks for Genetic conditionsVideo library
Description
Clopidogrel resistance is a condition in which the drug clopidogrel is less effective than normal in people who are treated with it. Clopidogrel (also known as Plavix) is an antiplatelet drug, which means that it prevents blood cells called platelets from sticking together (aggregating) and forming blood clots. This drug is typically given to prevent blood clot formation in individuals with a history of stroke; heart attack; a blood clot in the deep veins of the arms or legs (deep vein thrombosis); or plaque buildup (atherosclerosis) in the blood vessels leading from the heart, which are opened by placement of a small thin tube (stent).
People with clopidogrel resistance who receive clopidogrel are at risk of serious, sometimes fatal, complications. These individuals may have another heart attack or stroke caused by abnormal blood clot formation; those with stents can develop blood clots (thromboses) within the stents, impeding blood flow.
People with clopidogrel resistance can be divided into two categories: intermediate metabolizers and poor metabolizers. Intermediate metabolizers are able to process some clopidogrel, so they receive partial benefit from the treatment but are not protected from developing a harmful blood clot. Poor metabolizers process little or no clopidogrel, so they receive very limited benefit from the treatment and are at risk of forming a harmful blood clot.
Clopidogrel resistance does not appear to cause any health problems other than those associated with clopidogrel drug treatment.
Inheritance patterns
The source lists the following possible inheritance patterns: Autosomal codominant. More than one pattern can apply in different cases.
Related genes
Other names
CYP2C19-related poor drug metabolism
Poor metabolism of clopidogrel
Resistance to clopidogrel
Patient picks for Genetic conditions

Hormones
Insulin resistance: the common thread linking metabolic conditions
You may have come across the term “insulin resistance” - particularly if you’ve been having conversations about weight and metabolic health - but be a little unclear about what it actually is. Whilst it’s easy to think insulin resistance just means reduced glucose control, it’s actually far more complex than that. Dr Nienke Lees, Women's Health Service Lead, Genwell UK, explains what it means and how it connects conditions including type 2 diabetes, fatty liver disease, cardiovascular disease, and PCOS.
by Dr Nienke Lees

Treatment and medication
Antibiotic resistance: a hidden health crisis
If you have a bacterial infection, your doctor may prescribe antibiotics. However, unnecessary use of antibiotics can weaken their effectiveness, leading to antibiotic resistance and making future infections harder to treat. Doctors and other appropriately qualified health professionals will only prescribe antibiotics where there is a critical need.
by Victoria Raw

Drug interactions checker
Can I take Lansoprazole and Clopidogrel together?
Lansoprazole may make clopidogrel less effective at preventing blood clots. This could potentially increase your risk of having a heart attack or stroke while taking both medicines together.

Drug interactions checker
Can I take Co-codamol and Clopidogrel together?
Taking co-codamol (which contains codeine) alongside clopidogrel may make the clopidogrel less effective at preventing blood clots. This could potentially increase your risk of having a heart attack or stroke.

Drug interactions checker
Can I take Atorvastatin and Clopidogrel together?
Taking atorvastatin and clopidogrel together may slightly reduce the effectiveness of clopidogrel in preventing blood clots. However, for most people, the benefits of taking both medicines to prevent heart attacks or strokes far outweigh this small risk.

Drug interactions checker
Can I take Mirtazapine and Clopidogrel together?
Taking mirtazapine and clopidogrel together may increase your risk of bleeding. This includes bruising more easily, nosebleeds, or more serious bleeding inside the body.
Related patient information and medicines

Patient information leaflet
Antiphospholipid syndrome
Antiphospholipid syndrome is sometimes called Hughes' syndrome. Antiphospholipid syndrome (APS) - also called Hughes' syndrome - makes blood more likely than normal to clot (a thrombophilia Thrombophilia ). Clopidogrel Clopidogrel to prevent blood clots , dipyridamole Dipyridamole to prevent blood clots and aspirin Aspirin to prevent blood clots.

Patient information leaflet
Heart disease
Treatments include the following: Medication Medicines are used to: Thin the blood and prevent blood clots forming in the heart and elsewhere in the body (eg, aspirin, clopidogrel, warfarin, apixaban) Improve blood flow to the heart (eg, nicorandil, ranolazine, ramipril) Slow down the heart rate if it is beating too fast (eg, bisoprolol,.

Patient information leaflet
Broken or bruised ribs
You have a history of heart disease, stroke or peripheral ar... You have asthma, high blood pressure, kidney disease or may be pregnant. You are already taking aspirin (including low-dose aspirin Aspirin to prevent blood clots ) or clopidogrel Clopidogrel to prevent blood clots. You are taking these painkillers for long periods - say, for over two.

Patient information leaflet
Transient ischaemic attack
A transient ischaemic attack (TIA) causes symptoms similar to a stroke. The most commonly used long-term antiplatelet medicine following a stroke or TIA is clopidogrel Clopidogrel to prevent blood clots. Sometimes, once a TIA or minor stroke has been diagnosed, people are offered a short course of two antiplatelet medications together (aspirin and.

Patient information leaflet
Peripheral arterial disease
Peripheral arterial disease, also called peripheral vascular disease, is a narrowing of the blood vessels (arteries). Surgery is only needed in ... Medicines A medicine called clopidogrel Clopidogrel to prevent blood clots is usually advised. This does not help with symptoms of PAD but helps to prevent blood clots (thromboses) forming in blood.

Patient information leaflet
Aspirin and other antiplatelet medicines
Most people who have a cardiovascular disease (for example, angina, peripheral arterial disease, or a previous heart attack, transient ischaemic attack (TIA) or stroke) take a low-dose aspirin (75 mg) each day or clopidogrel (75 mg) each day. For those with peripheral arterial disease (damage to the arteries in the legs), clopi... After a stroke.
Further reading and references
- Clopidogrel resistance; MedlinePlus, National Library of Medicine.
- Hirota T, Eguchi S, Ieiri I. Impact of genetic polymorphisms in CYP2C9 and CYP2C19 on the pharmacokinetics of clinically used drugs. Drug Metab Pharmacokinet. 2013;28(1):28-37. doi: 10.2133/dmpk.dmpk-12-rv-085. Epub 2012 Nov 20.
- Niu X, Mao L, Huang Y, Baral S, Li JY, Gao Y, Xia YP, He QW, Wang MD, Li M, Zou L, Miao XP, Hu B. CYP2C19 polymorphism and clinical outcomes among patients of different races treated with clopidogrel: A systematic review and meta-analysis. J Huazhong Univ Sci Technolog Med Sci. 2015 Apr;35(2):147-156. doi: 10.1007/s11596-015-1404-7. Epub 2015 Apr 16.
- Scott SA, Sangkuhl K, Stein CM, Hulot JS, Mega JL, Roden DM, Klein TE, Sabatine MS, Johnson JA, Shuldiner AR; Clinical Pharmacogenetics Implementation Consortium. Clinical Pharmacogenetics Implementation Consortium guidelines for CYP2C19 genotype and clopidogrel therapy: 2013 update. Clin Pharmacol Ther. 2013 Sep;94(3):317-23. doi: 10.1038/clpt.2013.105. Epub 2013 May 22.
- Society for Cardiovascular Angiography and Interventions; Society of Thoracic Surgeons; Writing Committee Members; Holmes DR Jr, Dehmer GJ, Kaul S, Leifer D, O'Gara PT, Stein CM. ACCF/AHA Clopidogrel clinical alert: approaches to the FDA "boxed warning": a report of the American College of Cardiology Foundation Task Force on Clinical Expert Consensus Documents and the American Heart Association. Circulation. 2010 Aug 3;122(5):537-57. doi: 10.1161/CIR.0b013e3181ee08ed. Epub 2010 Jun 28. No abstract available.
- Uppugunduri CR, Daali Y, Desmeules J, Dayer P, Krajinovic M, Ansari M. Transcriptional regulation of CYP2C19 and its role in altered enzyme activity. Curr Drug Metab. 2012 Oct;13(8):1196-204. doi: 10.2174/138920012802850146.
Share your thoughts or experiences with others in our patient communities.
Sign up to the Patient newsletter
Your weekly dose of clear, trustworthy health advice - written to help you feel informed, confident and in control.
By subscribing you accept our Privacy Policy. You can unsubscribe at any time. We never sell your data.

